- Home
- TPST vs MOGU Comparison
TPST vs MOGU Comparison
Compare TPST & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPST | MOGU |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 15.3M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TPST | MOGU |
|---|---|---|
| Price | $1.10 | $1.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 241.2K | 3.4K |
| Earning Date | 05-08-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $295,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $1.27 |
| 52 Week High | $12.22 | $8.10 |
Technical Indicators
Market Signals| Indicator | TPST | MOGU |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 49.32 |
| Support Level | $1.02 | $1.85 |
| Resistance Level | $1.26 | $2.12 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 59.98 | 39.71 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.